Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly those targeting central nervous system disorders. Its structure supports the development of agents with potential antipsychotic or cognitive-enhancing properties. The amine functionality allows for further chemical modifications, making it valuable in creating novel drug candidates. Also investigated for use in radiolabeled forms for positron emission tomography (PET) imaging studies due to the presence of fluorine, which can facilitate labeling with fluorine-18.